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Structure-Based Design of Phospholamban Mutants for Treatment of
Heart Failure
Simon J. Gruber, David D. Thomas.
Ca2þ cycling through the SR in muscle cells is largely controlled by the Ca-
pump (SERCA). SERCA transports Ca2þ into the SR, allowing muscles to re-
lax, and is inhibited by phospholamban (PLB) at submicromolar [Ca2þ]. PLB
inhibition can be relieved by adrenergic stimulation, leading to PLB phosphor-
ylation. Heart Failure (HF), which contributes to 12% of US deaths, can be
caused by a variety of genetic or environmental factors, but a common symp-
tom is decreased SERCA activity. We are using EPR and NMR to study the
relationships among structure, dynamics, and function of PLB, with the goal
of designing LOF-PLB mutants (PLBM) that can compete with WT-PLB and
thus relieve SERCA inhibition. Several studies have shown that a pseudophos-
phorylated PLB (S16E-PLB) is effective for gene therapy in rodents and sheep,
and we are using spectroscopic methods to refine this approach. We have de-
veloped a system for examining the function and interactions of SERCA and
PLB in HEK cells. Active SERCA is expressed and cells are co-transfected
with WT-PLB and/or PLBM to measure SERCA inhibition in living cells. Ef-
fects of PLB/PLBM on SERCA specific activity (s
1), as well as PLB oligo-
meric states are characterized in stable cells lines. We can also measure
a mutant’s ability to compete with WT-PLB by measuring fluorescence reso-
nance energy transfer (FRET) between labeled SERCA and WT-PLB. If
PLBM displaces WT-PLB, less energy is transferred between fluorophores
and a decrease in FRET is observed. Preliminary results have led to rAAV-
mediated expression of a PLBM (P21G) in cardiomyocytes of a rat HF model,
increasing contractility to near WT levels.
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Analyzing the Role of NCKX2 in Hippocampal Long Term Potentiation
Yuntian Zhang, Ray W. Turner, Jonathan Lytton.
Naþ/Ca2þ exchangers control clearance of cytosolic Ca2þ following a sig-
naling event when Ca2þ is elevated due to their low-affinity/high capacity
transport properties. NCKX2 is a member of the family of Kþ-dependent
Naþ/Ca2þ-exchangers, and is abundant in brain neurons. Targeted knock-
out of the NCKX2 gene results in a profound loss of long term potentiation
and an increase in long term depression at hippocampal Schaffer/CA1 syn-
apses. We examined the expression of a variety of synaptic molecules when
NCKX2 is knocked out to disclose the role of NCKX2 in hippocampal
plasticity. Co -localization experiments using confocal and electron micros-
copy were conducted to define the location of NCKX2 in hippocampus. Im-
munoblot results from whole brain lysates showed that GluR2/3 and
NMDA-receptor 1 were reduced in NCKX2 knockout mice. There was
no statistical difference in immunoblot for CamKII, PSD95, or GluR1 be-
tween wild type and the knockout. In hippocampus phospho-CamKII was
upregulated, and small but insignificant changes were found in the expres-
sion of other synaptic marker proteins. Co-localization analyses showed
minimal overlap of NCKX2 with either the post synaptic marker CamKII
or the presynaptic markers synapsin, synaptophysin or VGLUT-1. Immuno-
cytochemistry revealed a decrease in net MAP-2 label in the CA3 region of
knockout animals that correlates to a reduction in the number of neuronal
profiles and increase in DAPI-labeled nuclei, suggesting neuronal loss and
glial cell proliferation. From the above experiments, we can for first time
approach the idea of the exact location of NCKX2. Expression change
for various synaptic molecules in hippocampus is not obvious, but rather
loss of CA3 neurons and the associated Schaeffer collateral projection to
CA1, potentially resulting from changes in calcium dynamics when
NCKX2 is knocked out.
Protein Ligand Interactions: Receptors & Small
Molecules
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Anesthetic Modulation of Signal Transduction Pathways in the a4b2
nAchR Revealed by the Perturbation-Based Markovian Transmission
Model
Lu Tian Liu, Mingzhu Li, David Mowrey, Hsiao-Mei Lu, Jie Liang, Yan Xu,
Pei Tang.
The gating mechanism of ligand-gated ion channels and anesthetic modulation
of channel gating remain to be determined. In this study, we used the
perturbation-based Markovian transmission model to investigate the time-
dependent signal propagation in the neuronal nicotinic acetylcholine receptor
(a4b2 nAChR) under initial perturbations by agonist binding. Both open-and closed-channel a4b2 nAChR conformations in the presence and absence
of the anesthetic halothane, from our previous computational studies, were ex-
amined. We found that signal transduction in a4b2 resembles the conformation
wave mechanism. In all systems, the perturbation signal flows from the agonist-
binding sites up toward the main immunogenic region, then down to the bottom
of the beta barrel, followed by the extracellular (EC)/transmembrane (TM) in-
terface, and finally to the transmembrane domain, as measured by the time de-
pendence of the maximum probability flux. The EC domain of the open- and
closed-channel a4b2 conformations showed different dynamic responses to
the perturbation at the agonist-binding site: many more residues in the EC do-
main of the open-channel a4b2 nAChR exhibited frequent fluctuation. In the
system with halothane, the signal transduction within pre-TM1 (R207), Cys-
loop (F137, P138, F139), and TM2-TM3 linker (L271) slowed down in some
of the subunits, but speeded up in others. The changes in signal transduction
at the EC/TM interface may underlie the effects of anesthetics on the a4b2
nAChR. Supported by NIH (R01GM066358, R01GM056257,
R37GM049202).
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Catharanthine Alkaloids are Noncompetitive Inhibitors of Muscle-Type
Nicotinic Acetylcholine Receptors
Ruin Moaddel.
This is an attempt to characterize the binding sites and the mechanisms of
action of several catharanthine alkaloids including ibogaine, vincristine,
and vinblastine, on muscle-type nicotinic acetylcholine receptors (AChRs),
by comparing their pharmacological properties with that for the well charac-
terized high-affinity noncompetitive antagonist (NCA) phencyclidine (PCP).
In this regard, structural and functional approaches were used including ra-
dioligand equilibrium and competition binding assays using [3H]ibogaine
and the analog of PCP, [piperidyl-3, 4-3H(N)]-N-(1-(2 thienyl)cyclohexyl)-
3,4-piperidine ([3H]TCP), Ca2þ influx determinations, thermodynamic and
kinetic measurements using column-immobilized Torpedo AChRs, and mo-
lecular docking and dynamics studies The results established that: (a) the al-
kaloidsinhibit (5)-epibatidine-induced Ca2þ influx in embryonic muscle
AChRs with the following potencies (in mM): ibogaine (17 5 3) > vinblas-
tine (20 5 5) > vincristine (25 5 4), that are slightly higher than that for
PCP (31 5 2), (b) the alkaloids inhibit [3H]TCP binding, and ibogaine
and PCP inhibit [3H]ibogaine binding, to the desensitized Torpedo AChR
with higher affinity compared to the resting AChR, (c) ibogaine binds to
the Torpedo AChR by an entropy-driven process, and (d) ibogaine interacts
with a binding domain located between the serine (position 6’) and valine
(position 13’) rings, by a network of van der Waals and polar interactions.
Collectively our data indicate that catharanthine alkaloids block agonist-
activated ion channels by interacting with a binding domain that is shared
with PCP located between the serine and valine rings. This supports the
view that the catharanthine moiety, which is shared by ibogaine and vinca
alkaloids, is a minimum structural requirement for the interaction of these
molecules with the ion channel. In addition, ibogaine and vinca alkaloids
may induce and maintain the desensitized state by a mechanism where their
dissociation rates are decreased.
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A Combined Experimental and Simulation Approach to Develop Selective
High-Affinity Small-Molecule Inhibitors of Cannabinoid Receptors CB1/
CB2
Irene Meliciani, Nicole Volz, Viktor Rempel, Sonja Hinz, Tadeusz Karcz,
Christa E. Mu¨ller, Stefan Bra¨se, Wolfgang Wenzel.
The cannabinoid receptors belong to the membrane-bound G protein-coupled
receptor superfamily and are predominantly coupled via Gi/o proteins. The
CB1 receptor subtype is known to play an essential role in analgesia,
memory-impairment, spasmolysis and regulation of appetite. Selective agonists
for CB2 receptors show antiinflammatory and analgesic properties in animal
models [1]. Cannabinoid receptors are activated by three major groups of li-
gands, mammalian endocannabinoids, plant and synthetic cannabinoids (e.g.
THC from the plant Cannabis sativa). Here we investigated the interactions be-
tween the cannabinoid receptors type 1 and 2 (CB1/CB2) with a novel set of
coumarin derivatives.
Rational drug design for many GPCRs is complicated by the lack of receptor
crystal structures. To aid interpretation of the experiments we have therefore
constructed a model for the CB1 and CB2 receptors based on homology to bo-
vine rhodopsin (pdb-code 1U19) and performed ligand binding simulations for
a family of 39 coumarin derivatives applying an all-atom docking protocol us-
ing Flexscreen [2].
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ploit a hydrophobic cavity in the vicinity of the docking pose of known li-
gands. All novel ligands showed improved, affinities with respect to their
reference compounds, in good quantitative agreement between experiment
and simulation, some of them reaching nanomolar affinities. Studying a series
of site-specific mutations, we could computationally rationalize the receptor
selectivity of specific compounds to either preferentially bind CB1 or CB2,
respectively.
[1] S.H. Burstein and R.B. Zurier (2009) Cannabinoids, Endocannabinoids, and
Related Analogs in Inflammation,
AAPS J. 11(1), 109-119.
[2] H. Merlitz, B. Burghardt andW. Wenzel (2003) Application of the Stochas-
tic Tunneling Method to High Throughput Database Screening,
Chem. Phys. Lett. 370, 68-73.
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Field-Modulated Magnetic Birefringence Relaxation to Assay b-Adrener-
gic Receptor-Ligand Association
Louis H. Strong, Daniel B. Hall, Hiep-hoa Nguyen, Gyula Varadi.
We developed a platform for monitoring the association between biologically
active molecules and their cognate receptors based on measuring rate changes
of magnetic birefringence relaxation of superparamagnetic nanoparticles. The
method is particularly designed for rapid screening of display libraries and
mutant receptor libraries expressed in bacteria and yeast. The magnitude of
birefringence rate change after particle orientation in a magnetic field reflects
the difference of nanoparticle hydrodynamic volume upon formation of the
‘‘receptor-ligand complex’’. The rationale for using nanoparticle birefrin-
gence to identify ligand and receptor interactions is that it eliminates the
need for removing unbound ligands. We have previously demonstrated that
maghemite nanoparticles, decorated with ligand molecules, exhibit longer re-
laxation times when associated with proteins, viruses and small size microor-
ganisms. We utilize magnetic field-modulated birefringence to monitor
association between a ligand (alprenolol) immobilized on the surface of mag-
netic nanoparticles and b-adrenergic receptor overexpressed on the cell sur-
face of bacteria and yeast. Upon association of the ligand with the
receptor, we observed an increase in the birefringence rate constant, an effect
that was fully reversible by adding b-adrenergic competitor ligands. Rate con-
stant distributions were reconstructed using the Phase Function Method. We
show that birefringence signals can be used to monitor the dynamics of par-
ticle rotational alignment as well as rotational relaxation. Alignment dynam-
ics are characteristic of the number of accessible receptor sites while
relaxation characterizes the aggregate size. This novel approach is applicable
in systems where the interaction of ligand with cognate receptor does not ac-
tivate intracellular pathways and thus are difficult to monitor with a ratio-
fluorometric platform. This method will be useful for a broad range of
applications, including discovery research to develop small molecule drugs
and for identification of orphan receptors and biologically active peptides
and proteins from display libraries.
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Transient Kinetics of Nucleotide Binding to the P-glycoprotein Multidrug
Transporter
Miguel R. Lugo, Joseph W.K. Chu, Frances J. Sharom.
The P-glycoprotein multidrug transporter (Pgp) is a member of the ABC
(ATP-binding cassette) superfamily of proteins, and contains two highly con-
served cytosolic nucleotide-binding domains (NBDs). These domains couple
ATP hydrolysis to the export of a variety of hydrophobic natural products,
chemotherapeutic drugs and peptides. Pgp ATPase activity has been exten-
sively characterized, but many details of the catalytic cycle of ATP hydro-
lysis remain unexplored. The fluorescent nucleotide analogue, TNP-ADP,
interacts with the NBDs of Pgp, and the stoichiometry and affinity of binding
were previously determined in our laboratory. Transient kinetic methods are
commonly used to investigate the mechanism of molecular processes over
a time-scale from milliseconds to hundreds of seconds. In this work, we
studied the binding of TNP-ADP to Pgp using rapid stopped-flow kinetics.
In these experiments, the binding reaction was monitored by following dif-
ferent fluorescent signals, under pseudo-first-order conditions (excess ligand).
The time course of TNP-ADP binding displayed five relaxation times (ti’s)
over a time-span of 300 sec, which correspond to at least five different tran-
sitions. All the relaxation times presented a strong temperature-dependence.
The time course of the reaction was analyzed by the computational tool
Global Kinetic Explorer (KinTek, USA), using several models of sequential
isomerizations after/before the fast bimolecular binding reaction. Also, theparameters were analyzed using the matrix projection operator technique
for kinetic data (Bujalowski et al., 2000, J. Mol. Biol. 295:831). Both ap-
proaches provide, for the first time, information about the rate constants
and fluorescent properties of the diverse intermediates formed during binding
of TNP-ADP to Pgp. Elucidation of the details of the interaction of nucleo-
tides with Pgp is of prime importance for formulation of a detailed mecha-
nism of action of the transporter.
This research is supported by a grant from the Canadian Cancer Society.
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Identification of an Efficacy Pharmacophore for m Opioid Receptor Li-
gands Using the Conformationally Sampled Pharmacophore (CSP)
Method
Jihyun Shim, Andrew Coop, Alexander D. MacKerell Jr.
m opioid receptor agonists and antagonists play a critical role in the treatment
of severe pain and as treatments for drug abuse. Their structure activity rela-
tionships (SAR) have been extensively investigated followed by lead optimi-
zation. However, challenges remain in improving the utility of m ligands with
respect to reducing adverse effects such as tolerance, dependence, constipa-
tion, etc. while maintaining the potency of current medicines. To facilitate
the meeting of these challenges, consensus pharmacophore models for diverse
classes of m opioid receptor ligands were established and we constructed pre-
dictive model differentiating agonists and antagonists activities using the con-
formationally sampled pharmacophore (CSP) method. The predictability of
the models was validated against a number of classes of opioids including
4,5-Epoxymorphinans, Diels-Alder adducts of thebaine, Benzomorphans,
Methadone, Fentanyl, and, notably, non-nitrogenous opioids; a collection of
compounds which have eluded a consensus SAR of opioids for decades.
The consensus model was derived by virtue of CSP method incorporating
flexibility of molecules through using all-accessible conformers in model de-
velopment and by eliminating any limitations associated with alignment pro-
cedures. The procedures to develop and features of the CSP model will be
presented.
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Probing Binding of Apelin to the Extracellular Loops of the Apelin Recep-
tor (APJ) in Lipid Mimetic Environments
Pascaline Ngweniform, Jan K. Rainey.
a Department of Biochemistry & Molecular Biology and b Department of
Chemistry, Dalhousie University, Halifax, NS B3H 1X5.
The apelin receptor, previously called APJ, is a G protein-coupled receptor
highly expressed in the central nervous system (CNS), cardiovascular system,
the adipoinsular axis and the mammary glands, among other tissues and organ
systems. The apelinergic system plays important biological functions in the
regulation of blood pressure, blood glucose, drinking behavior and food intake.
The action of this system is also implicated in tumour angiogenesis, diabetes
and cardiovascular diseases. In addition, the apelin receptor is a co-receptor
for human immunodeficiency virus type 1 (HIV1) and simian immunodefi-
ciency virus (SIV). Despite these roles, the mechanism of activation of apelin
receptor by its cognate ligand has not been studied at the molecular level. Fol-
lowing the ‘‘divide and conquer’’ approach for membrane protein characteriza-
tion, we present the biophysical characterization of the interaction of two
extracellular loops of the apelin receptor (extracellular loops 1, EL1 and 3,
EL3) with a fluorescently-tagged apelin analogue in lipid environment. Pep-
tides were synthesized by solid phase peptide synthesis and purified by high-
performance liquid chromatography. Characterization both of the peptides in
isolation and of the binding between apelin and EL peptides is provided using
circular dichroism spectroscopy, fluorescence resonance energy transfer and
nuclear magnetic resonance spectroscopy. These results provide insight into
understanding of the apelinergic system at the molecular level and provide
the first structural information on the apelin receptor for the development of
therapeutics targeting this system.
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Design and Biophysical Characterization of a Single Chain Four-alpha-
helix Bundle Protein Which Binds Volatile General Anesthetics
Lucia M. Morstadt, Qing Cheng Meng, Jonas S. Johansson.
In order to investigate the interaction of volatile general anesthetics with their
putative membrane protein targets, we designed a four-alpha-helix bundle
protein in a single protein chain. The four alpha helices, connected by three
8 glycine loops, had the sequence A, B, B’, A’. The DNA sequence was de-
signed with the goal of making helices with the same amino acid sequence
(helix A and A’, B and B’, respectively) as different as possible in their
